Top

Review of Industrial Organization

Published in:

28-03-2018

Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics”

Authors: Christopher M. Snyder, Victor J. Tremblay

Published in: Review of Industrial Organization | Issue 1/2018

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

This article introduces the special issue on the intersection between industrial organization and healthcare economics. This intersection has received increasing research interest, growing from 2% of the industrial-organization literature in 1991 to 6% in 2016. We describe the nine included articles, which cover a range of healthcare markets that include hospital services, insurance, and pharmaceuticals.

next article Vertical Alignment Between Hospitals and Physicians as a Bargaining Response to Commercial Insurance Markets

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Available only for authorised users

For excellent surveys of various segments of the healthcare market, see Gaynor et al. (2015) on hospital-services and insurance markets and Scherer (2000) on pharmaceuticals.

These figures were computed by dividing Research America (2007, 2016) estimates of U.S. R&D in healthcare by National Science Foundation estimates of total U.S. R&D.

Chandra, A., Finkelstein, A., Sacarny, A., & Syverson, C. (2016). Health care exceptionalism? Performance and allocation in the US health care sector. American Economic Review, 106, 2110–2144.CrossRef

Freedman, S., Lin, H. & Prince, J. (2018). Does competition lead to agglomeration or dispersion in EMR vendor decisions? Review of Industrial Organization. https://doi.org/10.1007/s11151-018-9624-1.

Gaynor, M., Ho, K., & Town, R. J. (2015). The industrial organization of health-care markets. Journal of Economic Literature, 53, 235–284.CrossRef

Ho, K., Pakes, A., & Shepard, M. (2018). The evolution of health insurer costs in Massachusetts, 2010–2012. Review of Industrial Organization. https://doi.org/10.1007/s11151-018-9623-2.

Horwitz, J. R., Hsuan, C., & Nichols, A. (2018). The role of hospital and market characteristics in invasive cardiac service diffusion. Review of Industrial Organization. https://doi.org/10.1007/s11151-018-9625-0.

Kremer, M., & Snyder, C. M. (2015). Preventives versus treatments. Quarterly Journal of Economics, 130, 1167–1239.CrossRef

Kremer, M., & Snyder, C. M. (2018). Preventives versus treatments redux: Tighter bounds on distortions in innovation incentives with an application to the global demand for HIV pharmaceuticals. Review of Industrial Organization. https://doi.org/10.1007/s11151-018-9621-4.

Kyle, M. (2018). Are important innovations rewarded? Evidence from pharmaceutical markets. Review of Industrial Organization (in review).

McCarthy, I., & Huang, S. (2017). Vertical alignment between hospitals and physicians as a bargaining response to commercial insurance markets. Review of Industrial Organization. https://doi.org/10.1007/s11151-017-9609-5.

Miller, K. S., & Wilson, W. W. (2017). Governance structure and exit: Evidence from California hospitals. Review of Industrial Organization. https://doi.org/10.1007/s11151-017-9595-7.

Olson, L. M., & Wendling, B. W. (2018). Estimating the causal effect of entry on generic drug prices using Hatch–Waxman exclusivity. Review of Industrial Organization. https://doi.org/10.1007/s11151-018-9627-y.

Research America. (2007). 2007 Investment in U.S. Health Research. Arlington, Virginia. Retrieved October 18, 2017 http://www.researchamerica.org/-polls-publications/-us-investment-health-research.

Research America. (2007). U.S. Investments in Medical and Health Research and Development, 2013–2015. Arlington, Virginia. Retrieved October 18, 2017, from http://www.researchamerica.org/-polls-publications/-us-investment-health-research.

Scherer, F. M. (2000). The pharmaceutical industry. In A. J. Culyer & J. P. Newhouse (Eds.), Handbook of Health Economics (Vol. 1B, pp. 1297–1336). Amsterdam: North Holland.

Scott Morton, F. M., Stern, A. D., & Stern, S. (2018). The impact of the entry of biosimilars: Evidence from Europe. Review of Industrial Organization (in review).

Title: Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics”
Authors: Christopher M. Snyder
Victor J. Tremblay
Publication date: 28-03-2018
Publisher: Springer US
Published in: Review of Industrial Organization / Issue 1/2018
Print ISSN: 0889-938X
Electronic ISSN: 1573-7160
DOI: https://doi.org/10.1007/s11151-018-9628-x

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft"

Springer Professional "Wirtschaft+Technik"

Other articles of this Issue 1/2018

The Evolution of Health Insurer Costs in Massachusetts, 2010–2012

The Impact of the Entry of Biosimilars: Evidence from Europe

Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity

Vertical Alignment Between Hospitals and Physicians as a Bargaining Response to Commercial Insurance Markets

Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets

The Role of Hospital and Market Characteristics in Invasive Cardiac Service Diffusion